Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Orthopaedic Implant Company (OIC) is a medical device manufacturer specializing in high-value, low-cost orthopedic trauma implants. Founded in 2010 and headquartered in Reno, Nevada, the company operates on a "value-based" model designed to reduce the financial burden of orthopedic procedures by offering FDA-approved, generic implants that cost significantly less than traditional brand-name products. OIC's extensive commercial portfolio includes intramedullary nails, plates, screws, and external fixation systems for hand, wrist, ankle, and hip fractures. In February 2024, OIC was acquired by Zeda, Inc., a leader in additive manufacturing, and now operates as a Zeda Health company. This acquisition integrates OIC's value-based designs with Zeda's advanced 3D printing technologies to enhance global access to affordable orthopedic care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Orthopaedic Implant Company.